Bruker Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
81,800.00
59,600.00
104,900.00
154,500.00
80,300.00
181,000
Depreciation, Depletion & Amortization
61,300.00
59,700.00
53,300.00
54,300.00
63,900.00
64,900
Other Funds
400.00
400.00
600.00
1,200.00
3,500.00
51,100
Funds from Operations
191,000.00
153,600.00
182,900.00
219,600.00
195,000.00
281,900
Changes in Working Capital
46,000.00
39,300.00
46,300.00
88,800.00
40,600.00
42,200
Net Operating Cash Flow
145,000.00
114,300.00
229,200.00
130,800.00
154,400.00
239,700
Capital Expenditures
50,300.00
33,800.00
34,200.00
37,100.00
43,700.00
Sale of Fixed Assets & Businesses
1,900.00
28,400.00
1,100.00
1,100.00
11,500.00
Purchase/Sale of Investments
-
192,600.00
40,700.00
38,500.00
68,300.00
Net Investing Cash Flow
60,000.00
201,900.00
103,700.00
22,500.00
31,200.00
Cash Dividends Paid - Total
-
-
-
25,800.00
25,400.00
Issuance/Reduction of Debt, Net
17,900.00
800.00
88,100.00
145,900.00
3,100.00
Net Financing Cash Flow
26,500.00
6,700.00
166,700.00
27,200.00
158,000.00
Net Change in Cash
128,100.00
119,200.00
52,400.00
74,700.00
17,000.00
Free Cash Flow
94,700.00
80,500.00
195,000.00
93,700.00
110,700.00
Deferred Taxes & Investment Tax Credit
7,400.00
9,200.00
29,400.00
22,700.00
28,200.00
15,100
Net Assets from Acquisitions
11,600.00
3,900.00
29,900.00
25,000.00
67,300.00
Change in Capital Stock
8,200.00
7,900.00
79,200.00
148,500.00
132,200.00
Exchange Rate Effect
16,600.00
38,300.00
11,200.00
6,400.00
17,800.00

About Bruker

View Profile
Address
40 Manning Road
Billerica Massachusetts 01821
United States
Employees -
Website http://www.bruker.com
Updated 07/08/2019
Bruker Corp. engages in the development, manufacture and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI) and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment is comprised of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group.